Page 16 - Demo

Myeloid Leukemia. Frontiers in Immunology, 2019.
2. Chun Chia Cheng, Po Nien Liao, Ai Sheng Ho, Ken Hong Lim, Jung shan Chang, Ying Wen Su,
Caleb Gon Shen Chen, Ya Wen Chiang, Bi Ling Yang, Huan Chau Lin, Yu Cheng Chang, Chun Chao Chang and Yi Fang Chang. STAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening. Journal of Biomedical Science, 2018.
3. Chun-Chia Cheng, Hsin-Chi Lin, Kaun-Jer Tsai, Ya-Wen Chiang, Ken-Hong Lim, Caleb Gon-Shen Chen, Ying-Wen Su, Cheng-Liang Peng, Ai-Sheng Ho, Ling Huang, Yu-Cheng Chang, Huan-Chau Lin, Jung shan Chang, Yi-Fang Chang. Epidermal growth factor induces STAT1 expression to exacerbate the IFNr-mediated PD-L1 axis in epidermal growth factor receptor-positive cancers. Molecular Carcinogenesis, 2018.
4. M.J. Chen, I.C. Wu, Y.J. Chen, T.-E. Wang, Y.F. Chang, C.L. Yang, W.C. Huang, W.K. Chang, B.S. Sheu, M,S. Wu, J.T. Lin, C.H. Chu. Nutrition therapy in esophageal cancer—Consensus statement of the Gastroenterological Society of Taiwan. Diseases of the esophagus, 2018.
5. Chun-Chia Chenga, Kuei-Fang Choua, Cheng-Wen Wu, Nai-Wen Sua,, Cheng-Liang Peng, Ying- Wen Sua, Jung shan Chang, Ai-Sheng Ho, Huan-Chau Lina, Caleb Gon-Shen Chena,Bi-Ling Yang, Yu-Cheng Changa, Ya-Wen Chiang, Ken-Hong Lima, Yi-Fang Chang. EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer. Lung Cancer, 2018.
6. Bin-Bin Shih, Yi-Fang Chang, Chun-Chia Cheng, Hao-Jhih Yang, Kang-Wei Chang,Ai-Sheng Ho, Hua-Ching Lin, Chun Yeh, Chun-Chao Chang. SPECT imaging evaluation of111indium-chelated cetuximab for diagnosingEGFR-positive tumor in an HCT-15-induced colorectal xenograft. Journal of the Chinese Medical Association, 2017.
7. Chun-ChiaCheng, JungshanChang, StanleyChing-ChengHuang, Huan-ChauLin, Ai-ShengHo, Ken- HongLim, Chun-ChaoChang, LingHuang, Yu-ChengChang, Yi-FangChang*, Cheng-WenWu. YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells. PLoS ONE, 2017
8. Yi-Hao Chiang, Yu-Cheng Chang, Huan-Chau Lin, Ling Huang, Chun-Chia Cheng, Wei-Ting Wang, Hung-I Cheng, Nai-Wen Su1, Caleb Gon-Shen Chen, Johnson Lin, Yi-Fang Chang, Ming- Chih Chang, Ruey-Kuen Hsieh, Wen-Chien Chou, Ken-Hong Lim and Yuan-Yeh Kuo. Germline variations at JAK2, TERT, HBS1L-MYB and MECOM and the risk of myeloproliferative neoplasms in Taiwanese population. Oncotarget, 2017.
9. Yu-Cheng Chang, Huan-Chau Lin, Yi-Hao Chiang, Caleb Gon-Shen Chen, Ling Huang, Wei-Ting Wang, Chun-Chia Cheng, Johnson Lin1, Yi-Fang Chang, Ming-Chih Chang, Ruey-Kuen Hsieh1, Shu-Jen Chen, Ken-Hong Lim, Yuan-Yeh Kuo. Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms. Med Oncol, 2017.
10.Chi-Long Chen, Chun-Yi Chiang, Kuang-Wen Liao, Shu-Yi Ho, Yi-Fang Chang, Ken-Hong Lim, Ruey-Kuen Hsieh, Yu-Ling Lin, Ying-Wen Su. cIAP-2 Expression Increases in Elderly Patients with Squamous Cell Carcinoma of the Head and Neck. International Journal of Gerontology, 2017.
17